Status:
UNKNOWN
Metabolic and Prolonged Satiety Effects of a Breakfast Kit
Lead Sponsor:
Universidade do Porto
Collaborating Sponsors:
Center for Health Technology and Services Research
NOVA Medical School
Conditions:
Diet Habit
Eligibility:
All Genders
23-38 years
Phase:
NA
Brief Summary
The mobilizing programme MobFood - mobilizing scientific knoweledge and technology to answer the current nutrition market challenges - is formed by a consortium of 47 collaborative entities, between t...
Eligibility Criteria
Inclusion
- Male or female;
- Born between 1981 and 1996;
- Body mass index (BMI) between 18.5 kg/m2 and 24.9 kg/m2;
- Normoglycemic according to American Diabetes Association criteria \[Fasting Plasma Glucose \< 100 mg/dl, 2-h plasma glucose value during a 75 g oral glucose tolerance test (OGTT) \< 140 mg/dl)\];
- Healthy.
Exclusion
- Overweight or obese (BMI ≥ 25,0 kg/m2);
- Recent body weight loss/gain \>10%, within previous 3 months;
- Being on a weight loss/other special diet (e.g. Paleo diet, Atkins diet, flexitarian diet or ketogenic diet), within previous 3 months;
- Clinically significant illness, including:
- type 1 or type 2 diabetes; liver disease e.g. cirrhosis; malignancy; pancreatitis or other malabsorption; gastrointestinal disorders e. g. intestinal bowel disorder, celiac disease; previous weight loss surgery e.g. bariatric surgery; chronic respiratory, neurological, psychiatric, musculoskeletal diseases/conditions; diagnosed eating disorders.
- Individuals who don't regularly consume breakfast;
- Having taken antibiotics within the 12 weeks prior to beginning the study;
- Taking other medication that could potentially affect body weight, glucose metabolism and/or appetite (e.g. GLP-1 analogues);
- Being engaged in competitive sports;
- Having \>14 or \>8 (males and females, respectively) alcoholic units/week; misuse of drugs;
- Having donated blood within one month prior to the beginning of the study;
- Nut or milk allergy, or other food allergy or intolerance that would compromise compliance with the study protocol;
- Pregnant or breastfeeding.
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2020
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04417504
Start Date
June 1 2020
End Date
October 31 2020
Last Update
June 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NOVA Medical School, NOVA University of Lisbon
Lisbon, Portugal